The counter-argument I keep hearing is that either NSS doesn't exist or if it does, then nobody in their right mind would buy the stock. Your article seems to put the lie to the former... the latter only applies to companies with weak prospects.
But it is certainly Convenient to have it be argued negatively both ways. All that may not matter in the end with IPIX and their coming PH II results.
The rubber meets the road when a company executes their business plan and money appears on the table. For IPIX this means a PH II home run for moderate to severe Covid-19. That's when one sees the float turn over, sometimes multiple times, as there is scrambling to stem losses, as the price skyrockets upward.
News 
Market Data 
Discover 
